Atlas

Form 483

APHROZONE INTERNATIONAL, INC. Form 483, 2018-09-17

FDA issued a Form 483 to APHROZONE INTERNATIONAL, INC. on 2018-09-17 with 1 public-safe observation.

483· Form 483 issuedHuman Drugs1 observation

APHROZONE INTERNATIONAL, INC. · Los Angeles, United States · Issued September 17, 2018

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 Sep 2018
21 CFR 211.150

Written distribution procedure

Cited by Liming Zhang

Inspected site

AIAPHROZONE INTERNATIONAL, INC.Los Angeles, United States

Inspection team

LZLiming Zhang

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.150Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere